These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

156 related articles for article (PubMed ID: 11878046)

  • 1. Immunotherapy: a novel treatment for Non-Hodgkin's lymphoma.
    Hohenstein M
    Semin Oncol Nurs; 2002 Feb; 18(1 Suppl 1):10-5. PubMed ID: 11878046
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Monoclonal antibodies conjugated with radioisotopes for the treatment of Non-Hodgkin's lymphoma.
    Bush S
    Semin Oncol Nurs; 2002 Feb; 18(1 Suppl 1):16-21. PubMed ID: 11878047
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Treatment approaches and nursing considerations for non-Hodgkin's lymphoma.
    Long J; Versea L
    Semin Oncol Nurs; 2006 May; 22(2):97-106. PubMed ID: 16720232
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Antibody-targeted immunotherapy for treatment of non-Hodgkin's lymphoma.
    White CA; Berlfein JR; Grillo-López AJ
    Curr Pharm Biotechnol; 2000 Dec; 1(4):303-12. PubMed ID: 11467328
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Radioimmunotherapy for non-Hodgkin's lymphoma.
    Liebenguth P; Vogt Temple S
    Semin Oncol Nurs; 2006 Nov; 22(4):257-66. PubMed ID: 17095402
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A revolution in the treatment of non-Hodgkin's lymphoma.
    DeNardo GL; O'Donnell RT; Oldham RK; DeNardo SJ
    Cancer Biother Radiopharm; 1998 Aug; 13(4):213-23. PubMed ID: 10850358
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Newer treatments for non-Hodgkin's lymphoma: monoclonal antibodies.
    Maloney DG; Press OW
    Oncology (Williston Park); 1998 Oct; 12(10 Suppl 8):63-76. PubMed ID: 9830635
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Antibody therapy in non-Hodgkin's lymphoma: the role of rituximab, 90Y-ibritumomab tiuxetan, and alemtuzumab.
    Fietz T; Thiel E
    Recent Results Cancer Res; 2007; 176():153-63. PubMed ID: 17607923
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Current therapeutic approaches in the treatment of Non-Hodgkin's lymphoma.
    O'Brien T
    Semin Oncol Nurs; 2002 Feb; 18(1 Suppl 1):3-9. PubMed ID: 11878049
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Monoclonal antibody immunotherapy for malignant non-Hodgkin's lymphoma].
    Jourdan E; Richard B
    Presse Med; 2000 Apr; 29(13):717-21. PubMed ID: 10797826
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Rituximab: a new monoclonal antibody therapy for non-Hodgkin's lymphoma.
    Kosits C; Callaghan M
    Oncol Nurs Forum; 2000; 27(1):51-9. PubMed ID: 10660923
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Iodine 131 tositumomab in the treatment of non-Hodgkin's lymphoma.
    Smith S; Sweetenham JW
    Future Oncol; 2007 Jun; 3(3):255-62. PubMed ID: 17547519
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Monoclonal antibody therapy with autologous peripheral blood stem cell transplantation for non-Hodgkin's lymphoma.
    Aksentijevich I; Flinn IW
    Cancer Control; 2002; 9(2):99-105. PubMed ID: 12008655
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Antibody-targeted therapy for low-grade lymphoma.
    Vose JM
    Semin Hematol; 1999 Oct; 36(4 Suppl 6):15-20. PubMed ID: 10530712
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Treatment approaches and nursing applications for non-Hodgkin lymphoma.
    Long JM
    Clin J Oncol Nurs; 2007 Feb; 11(1 Suppl):13-21. PubMed ID: 17471823
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Successful treatment with Rituximab for relapsing immune thrombocytopenic purpura (ITP) associated with low-grade non-Hodgkin's lymphoma.
    Shvidel L; Klepfish A; Berrebi A
    Am J Hematol; 2001 Jul; 67(3):213-4. PubMed ID: 11391724
    [No Abstract]   [Full Text] [Related]  

  • 17. Prospects for immunotoxin therapy of non-Hodgkin's lymphoma.
    Grossbard ML; Fidias P
    Clin Immunol Immunopathol; 1995 Aug; 76(2):107-14. PubMed ID: 7614729
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The promising role of monoclonal antibodies for immunotherapy of the HIV-associated cancer, non-Hodgkin lymphoma.
    Rezahosseini O; Hanaei S; Hamadani M; Keshavarz-Fathi M; Rezaei N
    Int Rev Immunol; 2018 May; 37(3):165-173. PubMed ID: 29257907
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Monoclonal antibodies in the treatment of non-Hodgkin's lymphoma: moving targets.
    van Oers MH
    Neth J Med; 2009 Sep; 67(8):309-10. PubMed ID: 19767656
    [No Abstract]   [Full Text] [Related]  

  • 20. Current standards and future strategies in immunochemotherapy of non-Hodgkin's lymphoma.
    Motta G; Cea M; Carbone F; Augusti V; Moran E; Patrone F; Nencioni A
    J BUON; 2011; 16(1):9-15. PubMed ID: 21674844
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.